PD Dr. rer. pol. Jan Zeidler
Guest scientist
Research Director and Managing Director at the Center for Health Economics Research Hannover (CHERH)
Phone: +49 (0)511 762 - 4602
Fax: +49 (0)511 762 - 5081
E-mail: jan.zeidler@cherh.de
Research areas
Secondary data analyses
Health services research
Health economic evaluations
Memberships
PD Dr. Zeidler is a member of the German Society for Health Economics (DGGÖ), the Working Group on the Collection and Use of Secondary Data (AGENS), the German Society for Epidemiology (DGEpi) and the Association for Social Policy (VfS).
Career
Since 10/2013
Managing director and head of research at CHERH, Leibniz Universität Hannover
07/2020
Habilitation at Leibniz University Hannover with venia legendi in the field of business administration
Topic: SHI routine data analyses as an instrument of health economics and health services research
08/2012-12/2020
Head of the junior research group "Routine Data Analyses" at CHERH, Leibniz University Hannover
Since 11/2019
Research Associate, Leibniz University Hannover, Institute for Health Economics
12/2007 - 07/2012
Doctorate (Dr. rer. pol.)
Topic: Potentials and limitations of SHI routine data
Supervisor: Prof. Dr. J.-Matthias Graf von der Schulenburg
12/2007-10/2019
Research assistant, Leibniz University of Hanover, Institute for Insurance Management
10/2001 - 11/2007
Studied economics at the Leibniz University of Hanover (grade: 1.5)
Awards and prizes
03/2011
Conference Prize of the German Society for Health Economics (DGGÖ)
10/2008
Travel grant from the Victor Rizkallah Foundation in recognition of outstanding academic achievements
05/2008
Wilhelm Launhardt Prize of the Faculty of Economics and Business Administration at Leibniz Universität Hannover for outstanding performance in the diploma examination
04/2008
Leibniz Prize of the Association for the Promotion of Insurance Science at Leibniz Universität Hannover e.V. for the outstanding diploma thesis on "Cost analysis of rehabilitation in Germany"
Research projects
https://www.ihe.uni-hannover.de/de/zeidler/forschungsprojekte
Teaching
Lecture on hospital financing in the Public Health module "Social Medicine and Health Economics" in the study programmes in Human Medicine at Hannover Medical School
Various lectures and seminars at Leibniz University Hannover(https://www.wiwi.uni-hannover.de/de/studium/studienangebot-der-fakultaet/msc-wirtschaftswissenschaft/areas/he)
Full Publications in Peer-Reviewed Journals
1. Licker LV / Pardey N / Kreis K / Stahmeyer JT / Zinke S / Meyer-Olson D / Witte T / Hoeper K / Zeidler J. The cost of delayed access to specialist care – implications for medication costs in rheumatoid arthritis. Zeitschrift für Rheumatologie 2026; 85: 272–279
2. Rohde A / Klora M / Brand T / Zeidler J. Socioeconomic deprivation and survival among patients with non-small cell lung cancer (NSCLC): an investigation using population-based clinical cancer registration data from Lower Saxony (Germany) and a discussion of global evidence. Journal of Evidence, Continuing Education and Quality in Healthcare 2026; 201: 1–9
3. Märtens C / Stapel B / Heitland I / Zeidler J / Bauersachs J / Stahmeyer JT / Kahl KG: Depression severity and major cardiovascular events: findings from German insurance claims data. Journal of Psychosomatic Research 2026; 204: 112579
4. Feng X / Zimmermann P / Pardey N / Bassler S / Stahmeyer JT / Lacher M / Zeidler J. Preservation vs. resection? Paediatric and non-paediatric management patterns in ovarian torsion. Paediatric Reports 2026; 18: 32
5. Paumen T / Leidger A / Ralfs J / Modarressi A / Ozga AK / Möhl A / Daubmann A / Zapf A / Waldmann T / von Gottberg C / Kilian R / Pardey N / Zeidler J et al. Implementation and evaluation of family-based interventions within the Germany-wide Children of Mentally Ill Parents (CHIMPS) Network: Study protocol for three prospective, rater-blinded, cluster-randomised controlled multicentre trials. Frontiers in Psychiatry 2026; 16: 1735421
6. Stahmeyer JT / Zeidler J / Schütte S / Warnemünde-Jagau P / Eidt-Koch D / Schulte F / Breitner MH / Jankowski I / Herr A / Kahl KG. Digital healthcare services – A survey on the level of awareness and intention to use among people with depression. Das Gesundheitswesen 2025; 88: 382–388
7. Märtens C / Stapel B / Heitland I / Zeidler J / Kahl KG / Stahmeyer JT. Differences in the uptake of specific healthcare services among people diagnosed with depression – what role does social status play? Psychiatric Practice 2025; 52: 416–423
8. Engelke J / Klora M / Zeidler J / Brand T. FOLFIRINOX versus gemcitabine (plus paclitaxel) for pancreatic cancer – an analysis based on data from the Clinical Cancer Registry of Lower Saxony. Annals of Pancreatic Cancer 2025; 8: 8
9. Steinberg A / Boettcher J / Leidger A / Muntau AC / Denecke J / Kaiser N / Daubmann A / Zapf A / Wegscheider K / Ozga AK / Suling A / Bullinger M / Quitmann J / Dirmaier J / Witt S / Rezvani F / Mundlos C / Biehl L / Rassenhofer M / Fegert J / Tutus D / Willms G / Zeidler J / Pardey N / von der Schulenburg JM / Wiegand-Grefe S. Evaluation of the health-related quality of life and mental health of parents with children and adolescents with a rare disease based on the results of a randomised controlled trial to investigate a family-based intervention and an online intervention for affected families (CARE-FAM-NET) . Family Process 2025; 64:e70041
10. Pardey N / Schmidt R / Zeidler J / Hilbert A. Health economic evaluation of cognitive-behavioural therapy for adolescents with binge-eating disorder in Germany. International Journal of Eating Disorders 2025; 58: 1178–1183
11. Pardey N / Zeidler J / Blaser J / Becker N / Dingemann J / Ure B / Schukfeh N. Medical costs of patients undergoing oesophageal atresia repair: Mainly influenced by associated malformations. European Journal of Paediatric Surgery 2025; 35: 43–51
12. Janßen A / Pardey N / Zeidler J / Krauth C / Blaser J / Oedingen C / Worthmann H. Support from telestroke networks is associated with increased intravenous thrombolysis and reduced hospital transfers: A German claims data analysis. Health Economics Review 2024; 14: 100
13. Braun J / Albrecht K / Callhoff J / Haase I / Krause A / Lakomek HJ / Meyer-Olson D / Schmale-Grede R / Wagner U / Zeidler J / Zinke S / Voormann A / Specker C. Rheumatological care in Germany – Memorandum of the German Society for Rheumatology and Clinical Immunology. Journal of Rheumatology 2024; 83 (Suppl 2): S249–S284
14. Dreher M / Witte T / Hoeper K / Assmann G / Proft F / Poddubbny D / Murawski N / Triantafyllias K / Grodd M / Graf E / Fichtner UA / Binder H / Zeidler J / Hoeper JR / Callhoff J / Karberg K / Trautwein A / Schmidt RE / Schwarting A. Rheuma-VOR study: optimising healthcare for rheumatic diseases through multi-professional coordinating centres. Annals of the Rheumatic Diseases 2024; 83: 184–193
15. Hoeper JR / Schuch F / Steffens-Korbanka P / Gauler G / Welcker M / Wendler J / von Hinüber U / Meyer SE / Schwarting A / Zeidler J / Witte T / Meyer-Olson D / Hoeper K. Delegation of medical tasks to rheumatology specialist assistants: effects on depression and anxiety in patients with rheumatoid arthritis. Journal of Rheumatology 2024; 83: 407–415
16. De Jong L / Schmidt T / Stahmeyer JT / Eberhard S / Zeidler J / Damm K. Informal care and employment: factors influencing willingness. Journal of Evidence, Continuing Education and Quality in Healthcare (ZEFQ) 2023; 178: 29–36
17. Zimmermann P / Krämer S / Pardey N / Bassler S / Stahmeyer JT / Lacher M / Zeidler J. Management of children and adolescents with chest trauma in paediatric and non-paediatric departments – a claims data analysis. Children 2023; 10: 512
18. Duess JW / Lange A / Zeidler J / Blaser J / Dingemann C / Ure BM / Lacher M / Gosemann JH / Hofmann DA. Appendiceal carcinoids in children – Prevalence, treatment and outcome in a large nationwide paediatric cohort. Medicina 2023; 59: 80
19. Pardey N / Zeidler J / Nellenschulte TF / Stahmeyer JT / Hoeper K / Witte T. Methotrexate treatment prior to the use of biologics in rheumatoid arthritis – An analysis of compliance with guidelines. Zeitschrift für Rheumatologie 2023; 82: 573–579
20. De Jong L / Schmidt T / Stahmeyer JT / Eberhard S / Zeidler J / Damm K. Willingness to provide informal care to older adults in Germany – a discrete choice experiment. European Journal of Health Economics 2022; 24: 425–436
21. De Jong L / Zeidler J / Damm K. A systematic review to identify the use of stated preference research in the field of care for older adults. European Journal of Ageing 2022; 19: 1005–1056
22. Stahmeyer JT / Märtens C / Eidt-Koch D / Kahl KG / Zeidler J / Eberhard S. Care provision for people diagnosed with depression. Ärzteblatt 2022; 119: 458–465
23. Haufe S / Boeck HT / Boyen J / Kueck M / van Rhee CC / von der Schulenburg JM / Zeidler J / Schmidt T / Holzwart D / Häckl S / Koch A / Tegtbur U. Impact of electric-assisted bicycles on physical activity targets: a nationwide cohort study. BMJ Open Sport & Exercise Medicine 2022; 8:e001275
24. Litzkendorf S / Zeidler J / Eidt-Koch D / von der Schulenburg JM. Sustainable funding for Centres of Excellence for Rare Diseases in Germany – current situation and proposed solutions. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2022; 65: 872–880
25. Dülsen P / Barck K / Daubmann A / Höller A / Zeidler J / Kilian R / Wiegand-Grefe S / Baumeister H. Clinical and cost-effectiveness of a guided internet-based intervention for children (aged 12 to 18) of parents with mental disorders (iCHIMPS): Study protocol of a multicentre cluster-randomised controlled trial. Frontiers in Digital Health 2022; 4: 816412
26. Kreis K / Horenkamp‑Sonntag D / Schneider U / Zeidler J / Glaeske G / Weissbach L. Safety and survival of docetaxel and cabazitaxel in metastatic castration‑resistant prostate cancer. BJU International 2021; 129: 470–479
27. Stahmeyer JT / Hamp S / Zeidler J / Eberhard S. Healthcare expenditure and the role of age: a detailed analysis of the costs of survivors and deceased patients. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021; 64: 1307–1314
28. Pardey N / Kreis K / Schmidt T / Stahmeyer JT / Krauth C / Zeidler J. Determinants of colorectal cancer screening in Germany: a claims data analysis. Zeitschrift für Gastroenterologie 2021; 59: 644–656
29. Böckle C / Blaser J / Schukfeh N / Zeidler J / Ure BM / Dingemann J. Analysis of pulmonary surgery in children and adolescents in Germany: who is doing what? European Journal of Paediatric Surgery 2021; 32: 327–333
30. Kreis K / Swart E / Gothe H / Zeidler J. Routine data in the Innovation Fund – relevance and process-oriented recommendations for action. Health and Social Policy 2021; 3: 44–51
31. Stahmeyer JT / Hemmerling M / Burger B / Eberhard S / Krauth C / Zeidler J / Herr A / Weseloh H / Rossol S. The prevalence of diagnosed non-alcoholic fatty liver disease (NAFLD) in the German population – An analysis based on routine statutory health insurance data. Journal of Gastroenterology 2021; 59: 851–858
32. De Jong / Stahmeyer JT / Eberhard S / Zeidler J / Damm K. Willingness and preparedness to provide care: interviews with individuals of different ages and with different caregiving experiences. BMJ Geriatrics 2021; 21: 207
33. Scheel K / Franke T / Weikert A / Dick M / Walter A / Zeidler J / Hartz T. Record linkage in clinical cancer registration: experiences and findings from Lower Saxony. German Medical Data Sciences: Bringing Data to Life 2021; 278: 101–109
34. Hoeper JH / Zeidler J / Meyer SE / Gauler G / Steffens-Korbanka P / Welcker M / Wendler J / Schuch F / von Hinueber U / Witte T / Meyer-Olson D / Hoeper K. Effect of nurse-led care on patient outcomes in APCA-/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target (T2T): a multicentre randomised controlled trial in Germany. RMD Open 2021; 7: e001627
35. Boettcher J / Filter B / Denecke J / Hot A / Daubmann A / Zapf A / Wegscheider K / Zeidler J / von der Schulenburg JM / Bullinger M / Rassenhofer M / Schulte-Markwort M / Wiegand-Grefe S. Evaluation of two family-based intervention programmes for children affected by rare diseases and their families – research network (CARE-FAM-NET): Study protocol for a rater-blinded, randomised, controlled, multicentre trial in a 2×2 factorial design. BMC Family Practice 2020; 21: 239
36. Zimmermann P / Schmidt T / Nelson J / Gosemann JH / Bassler S / Stahmeyer JT / Hirsch FW / Lacher M / Zeidler J. Paediatric solid organ injury – frequency of abdominal imaging is determined by the treating department. Medicine 2020; 99: 45 (e23057)
37. March S / Andrich S / Drepper J / Horenkamp-Sonntag D / Icks A / Ihle P / Kieschke J / Kollhorst B / Maier B / Meyer I / Müller G / Ohlmeier C / Peschke D / Richter A / Rosenbusch ML / Scholten N / Schulz M / Stallmann C / Swart E / Wobbe-Ribinski S / Wolter A / Zeidler J / Hoffmann F. Good Practice Data Linkage (GPD): a translation of the German version. International Journal of Environmental Research and Public Health 2020; 17: 7852
38. Kreis K / Horenkamp‑Sonntag D / Schneider U / Zeidler J / Glaeske G / Weissbach L. Treatment‑related healthcare costs of metastatic castration‑resistant prostate cancer in Germany: a claims data study. PharmacoEconomics – Open 2020; 5: 299–310
39. Kreis K / Plöthner M / Schmidt T / Seufert R / Schreeb K / Jahndel V / Maas S / Kuhlmann A / Zeidler J / Schramm A. Healthcare costs associated with breast cancer in Germany: A claims data analysis. European Journal of Health Economics 2020; 21: 451–464
40. De Jong L / Stahmeyer JT / Eberhard S / Zeidler J / Damm K. “But in many cases, one then comes up against specific challenges” – nursing advisers on legislative changes and the challenges of their work: A qualitative study. Journal of Evidence, Continuing Education and Quality in Healthcare 2020; 150: 65–72
41. Babac A / von Friedrichs V / Litzkendorf S / Zeidler J / Damm K / von der Schulenburg JM. Integrating patient perspectives in medical decision-making: A qualitative interview study examining potentials within the rare disease information exchange process in practice. BMC Medical Informatics and Decision Making 2019; 19: 188
42. Heßmann P / Zeidler J / Stahmeyer J / Eberhard S / Vogelgsang J / Abdel-Hamid M / Wolff-Menzler C / Wiltfang J / Kis B. Claims data analysis on the dispensing of tricyclic antidepressants among patients with dementia in Germany. Frontiers in Pharmacology 2019; 10: 841
43. Kreis K / Aumann-Suslin I / Lüdeke A / Wegewitz U / Zeidler J / von der Schulenburg JM. Costs of isocyanate-related occupational diseases: A systematic review. Journal of Occupational and Environmental Hygiene 2019; 16: 446–466
44. March S / Andrich S / Drepper J / Horenkamp-Sonntag D / Icks A / Ihle P / Kieschke J / Kollhorst B / Maier B / Meyer I / Müller G / Ohlmeier C / Peschke D / Richter A / Rosenbusch ML / Scholten N / Schulz M / Stallmann C / Swart E / Wobbe-Ribinski S / Wolter A / Zeidler J / Hoffmann F. Good Practice in Data Linkage (GPD). Das Gesundheitswesen 2019; 81: 1–16
45. Klora M / Zeidler J / Bassler S / Hirsch FW / Gosemann JH / Zimmermann P. The frequency of neuroimaging for paediatric minor brain injury is determined by the primary treating medical department. Medicine 2019; 98: e16320
46. Neubauer S / Zeidler H / Linder R / Zeidler J. Guideline-compliant prescribing of disease-modifying drugs in patients with rheumatoid arthritis – an analysis based on routine statutory health insurance data. Deutsche Medizinische Wochenschrift 2019; 144: 70–79
47. Winkelmann C / Neumann T / Zeidler J / Prenzler A / Vogt B / Wacker F. Health technology assessments in radiology in Germany: lack of demand, lack of supply. Advances in the Field of X-rays and Imaging Techniques 2019; 191: 635–642
48. Plöthner M / Schmidt K / De Jong L / Zeidler J / Damm K. Needs and preferences of informal carers regarding outpatient care for the elderly: a systematic literature review. BMC Geriatrics 2019; 19: 82
49. De Jong L / Plöthner M / Stahmeyer JT / Eberhard S / Zeidler J / Damm K. Informal and formal care preferences and expected willingness to provide care for older people in Germany: protocol for a mixed-methods study. BMJ Open 2019; 9:e023253
50. Götz G / Klora M / Zeidler J / Eberhard S / Bassler S / Mayer S / Gosemann JH / Lacher M. Surgery for ureteropelvic junction obstruction (UPJO) – a comparison of outcomes in relation to surgical technique and surgical discipline in Germany. European Journal of Paediatric Surgery 2018; 29: 033–038.
51. Heßmann P / Zeidler J / Neubauer S / Abdel-Hamida M / Stahmeyer J / Eberhard S / Wolff-Menzler C / Wiltfang J / Kis B. Continuity of treatment with benzodiazepines in patients with dementia: an analysis of German health insurance claims data. International Clinical Psychopharmacology 2018; 33: 282–289.
52. Heßmann P / Dodel R / Baum E / Müller MJ / Paschke G / Kis B / Zeidler J / Klora M / Reese JP / Balzer-Geldsetzer M. Prescription of benzodiazepines and related drugs in patients with mild cognitive deficits and Alzheimer’s disease. Pharmacopsychiatry 2018; 52: 84–91
53. March S / Antoni M / Kieschke J / Kollhorst B / Maier B / Müller G / Sariyar M / Schulz M / Swart E / Zeidler J / Hoffmann F. Quo vadis data linkage in Germany? An initial assessment. Das Gesundheitswesen 2018; 80: e20–e31
54. Klora M / Zeidler J / Linder R / Kis B / Hessmann P / Verheyen F / von der Schulenburg JM. Determinants of ADHD diagnosis – An analysis based on routine statutory health insurance data. Advances in Neurology and Psychiatry 2018; 86: 1–10
55. Heßmann P / Dodel R / Baum E / Müller MJ / Seeberg G / Kis B / Zeidler J / Klora M / Reese JP / Balzer-Geldsetzer M. Antidepressant medication in a German cohort of patients with Alzheimer’s disease. International Journal of Clinical Pharmacology and Therapeutics 2018; 56: 101–112
56. Linder R / Zeidler J / Verheyen F / von der Schulenburg JM / Haverich A / Schilling T. Guidelines versus reality: is coronary stent placement in three-vessel disease the norm or the exception? European Journal of Health Economics 2018; 19: 821–830
57. Heßmann P / Dodel R / Baum E / Müller MJ / Paschke G / Kis B / Zeidler J / Klora M / Reese JP / Balzer-Geldsetzer M. Use of anti-dementia drugs in German patients with Alzheimer’s disease. International Clinical Psychopharmacology 2018; 33: 103–110
58. Heßmann P / Dodel R / Baum E / Müller MJ / Paschke G / Kis B / Zeidler J / Klora M / Reese JP / Balzer-Geldsetzer M. Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in Germany. International Journal of Psychiatry in Clinical Practice 2017; 22: 232–239
59. Klora M / Zeidler J / May M / Raabe N / von der Schulenburg JM. Evaluation of GP-centred care in Germany based on routine statutory health insurance data from AOK Rheinland/Hamburg. Journal of Evidence, Continuing Education and Quality in Healthcare 2017; 120: 21–30
60. Pauer F / Litzkendorf S / Göbel J / Storf H / Zeidler J / von der Schulenburg JM. Rare Diseases on the Internet: An Assessment of the Quality of Online Information. Journal of Medical Internet Research 2017; 19:e23
61. Litzkendorf S / Pauer F / Zeidler J / Göbel J / Storf H / von der Schulenburg JM. Central information portal on rare diseases – implementation of quality- and needs-oriented information management. Federal Health Bulletin: Health Research and Health Protection 2017; 60: 494–502
62. Schmidt K / Marten O / Kühne C / Zeidler J / Frank M. Factors influencing the choice of practice location by general practitioners in rural and urban areas of Lower Saxony. Health Economics & Quality Management 2017; 22: 280–289
63. Dingemann C / Dietrich J / Zeidler J / Blaser J / Gosemann JH / Lacher M / Ure BM. Surgical management of congenital abdominal wall defects in Germany: A population-based study and comparison with literature reports. European Journal of Paediatric Surgery 2017; 27: 516–525
64. Krack G / Zeidler H / Zeidler J. Dosing analyses applied to claims data on TNF inhibitor treatment among patients with rheumatoid arthritis: a systematic review of the methods used. Drugs – Real World Outcomes 2016; 3: 265–278
65. Gosemann JH / Lange A / Zeidler J / Blaser J / Dingemann C / Ure BM / Lacher M. Appendectomy in the paediatric population – a German nationwide cohort analysis. Langenbeck’s Archives of Surgery 2016; 401: 651–659
66. Dietrich J / Zeidler J / Dingemann C / Blaser J / Gosemann JH / Ure BM / Lacher M / von der Schulenburg JM. Cost analysis of patients undergoing surgical correction of oesophageal atresia or gastroschisis based on routine statutory health insurance data. Health Economics & Quality Management 2016; 21: 242–249
67. Neubauer S / Zeidler J / Schilling T / Engel S / Linder R / Verheyen F / Haverich A / von der Schulenburg JM. Suitability and application of routine statutory health insurance (GKV) data for reviewing clinical practice guidelines, using left heart failure as an example. Das Gesundheitswesen 2016; 78: e135–e144
68. Neubauer S / Schilling T / Zeidler J / Lange A / Engel S / Linder R / Verheyen F / von der Schulenburg JM / Haverich A. The impact of guideline-based treatment on mortality in left ventricular failure. Herz 2016; 41: 614–624
69. Kreis K / Neubauer S / Lange A / Klora M / Zeidler J. Status and perspectives of claims data analyses in Germany – A systematic review. Health Policy 2016; 120: 213–226
70. Dingemann C / Dietrich J / Zeidler J / Blaser J / Gosemann JH / Ure BM / Lacher M. Early complications following oesophageal atresia repair: analysis of a German health insurance database covering a population of 8 million. Diseases of the Esophagus 2016; 29: 780–786
71. Klora M / Zeidler J / Linder R / Verheyen F / von der Schulenburg JM. Costs and treatment patterns of incident ADHD patients – a comparative analysis before and after the initial diagnosis. Health Economics Review 2015; 5: 40
72. Klora M / Zeidler J / Lublow D / Linder R / Verheyen F / von der Schulenburg JM. Age- and gender-specific costs and the provision of pharmacological treatments for ADHD patients. Das Gesundheitswesen 2015; 78: e23–e29
73. Lange A / Prenzler A / Bachmann O / Linder R / Neubauer S / Zeidler J / Manns MP / von der Schulenburg JM. Regional differences in healthcare for patients with inflammatory bowel disease in Germany. Health Economics Review 2015; 5: 29
74. Mennini FS / Marcellusi A / von der Schulenburg JM / Gray A / Levy P / Sciattella P / Soro M / Staffiero G / Zeidler J / Maggioni A / Schmieder RE. Cost of poor adherence to anti-hypertensive therapy in five European countries. European Journal of Health Economics 2015; 16: 65–72
75. Neubauer S / Cifaldi M / Mittendorf T / Ganguli A / Wolff M / Zeidler J. Biologic TNF-inhibiting agents for the treatment of rheumatoid arthritis: persistence and dosing patterns in Germany. Health Economics Review 2014; 4: 32
76. Bowles D / Lange A / Greiner W / Zeidler J. A cross-sectional analysis of the costs of care needs recognised under social welfare law. Zeitschrift für Sozialreform 2014; 60: 349–377
77. Lange A / Zeidler J / Braun S. One-year disease-related healthcare costs of incident vertebral fractures in osteoporotic patients. Osteoporosis International 2014; 25: 2435–2443
78. Zeidler J / Mahlich J / Greiner W / Heres S. Cost-effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany. Applied Health Economics and Health Policy 2013; 11: 509–521
79. Braun S / Russo L / Zeidler J / Linder R / Hodgkins P. Descriptive comparison of patients with newly diagnosed attention deficit/hyperactivity disorder in Germany: those receiving persistent drug treatment, those receiving non-persistent drug treatment, and those receiving non-drug treatment. Clinical Therapeutics 2013; 35: 673–685
80. Zeidler J / Lange A / Braun S / Linder R / Engel S / Verheyen F / von der Schulenburg JM. Calculating condition-specific costs in routine statutory health insurance data analyses using ADHD as an example – a comparison of methods. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 430–438
81. Braun S / Zeidler J / Linder R / Engel S / Verheyen F / Greiner W. Treatment costs of attention deficit hyperactivity disorder in Germany. European Journal of Health Economics 2013; 14: 939–945
82. Zeidler J / Mittendorf T / Müller R / von Kempis J. Biologic TNF-inhibiting agents for the treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payer’s perspective. Health Economics Review 2012; 2: 20
83. Zeidler J / Zeidler H / von der Schulenburg JM. Treatment of rheumatoid arthritis with methotrexate – analysis of healthcare provision aspects based on routine statutory health insurance data. Zeitschrift für Rheumatologie 2012; 71: 900–907
84. Zeidler J / Slawik L / Fleischmann J / Greiner W. The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective. Health Economics Review 2012; 2: 9
85. Damm K / Lange A / Zeidler J / Braun S / von der Schulenburg JM. Introduction of the new procedure code and its application in routine statutory health insurance data analyses – possibilities and limitations. Federal Health Bulletin: Health Research and Health Protection 2012; 55: 238–244
86. Braun S / Zeidler J / Mittendorf T / von der Schulenburg JM. Cost-effectiveness of quetiapine and haloperidol in patients with partially treatment-resistant schizophrenia. PharmacoEconomics German Research Articles 2010; 8: 21–29
87. Prenzler A / Zeidler J / Braun S / von der Schulenburg JM. Assessment of healthcare resources from the perspective of the German social security system. PharmacoEconomics German Research Articles 2010; 8: 47–66
88. Zeidler J / Mittendorf T / Vahldiek G / von der Schulenburg JM. Cost comparison analysis of outpatient and inpatient cardiological rehabilitation. Herz 2008; 33: 440–447
89. Zeidler J / Mittendorf T / Vahldiek G / Zeidler H / Merkesdal S. Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany. Rheumatology 2008; 47: 1527–1534
Articles in Non-Peer-Reviewed Journals
1. Bender S / Plück J / Schwarz M / Fimpel L / Zeidler J / Goertz-Dorten A / Schengel N. Transition from inpatient to outpatient treatment settings – the HomeBASE project. PiD - Psychotherapy in Dialogue 2025; 26: 50-53
2. Krack G / Schneider U / Zeidler J / Zöllner Y. The dggö Health Insurance Committee – The Innovation Fund on the threshold of standard care (?). Health Economics & Quality Management 2019; 24: 175–178
3. Plöthner M / Zeidler J / von der Schulenburg JM. Personalised medicine for selected cancers. Public Health Forum 2016; 24: 131–134
4. Zeidler J / Prenzler A / Amelung V / Krauth C / von der Schulenburg JM. Health economics research in Hanover – the Centre for Health Economics Research Hanover (CHERH). Public Health Forum 2013; 21: 23–24
5. Zeidler J / von Kempis J. Cost-effectiveness of biologics in rheumatoid arthritis. Rheuma Schweiz 2013; 5: 27–30
Editorials
1. Von der Schulenburg JM / Braun S / Zeidler J. Note from the editor, January 2021. Health Economics Review 2021; 11:12
2. Neubauer S / Kreis K / Klora M / Zeidler J. Access, use, and challenges of claims data analyses in Germany. European Journal of Health Economics 2017; 18: 533–536
Books or Chapters in Books
1. Pardey N / Zeidler J. Analysis of routine data in health services research. In: Kurscheid C / Balke-Karrenbauer N / Mollenhauer J (Eds.). Health Economics and Health Services Research. Springer: Berlin, 2025
2. Hoeper J / Schwarzbach C / Lohse U / Lange A / Zeidler J / von der Schulenburg JM. Epidemiology and Health Economics. In: Lammert F / Jansen PL / Lerch MM / Wedemeyer H (eds.). White Paper on Gastroenterology 2023/2024: Diseases of the Gastrointestinal Tract, the Liver and the Pancreas – Present and Future. De Gruyter: Berlin, 2023
3. Zeidler J / Lange A / von der Schulenburg JM. Health economics. In: Geier A / Canbay A / Lammert F (Eds.). Non-alcoholic fatty liver disease – Diagnosis and treatment of NAFLD. Springer: Berlin, 2022, 385–389
4. Zeidler J / Lange A / von der Schulenburg JM. Epidemiology and Health Economics. In: Lammert F / Jansen PL / Lerch MM (Eds.). White Paper on Gastroenterology 2020/2021: Diseases of the Gastrointestinal Tract, the Liver and the Pancreas – Present and Future. De Gruyter: Berlin, 2019
5. Zeidler J. Biosimilars – economic relevance and potential cost savings. In: Körber T / von der Schulenburg JM / Weber S (Eds.). Festschrift for Prof. Dr J.-Matthias Graf von der Schulenburg – Current Contributions to Insurance and Health Economics. Series on Insurance Science in Hanover, Hanover Series Vol. 27, Karlsruhe, 2018, 309–334
6. Neubauer S / Zeidler J / Lange A / von der Schulenburg JM. A process-oriented guide to the analysis and use of routine data from the statutory health insurance system. Nomos Verlag: Baden-Baden, 2017
7. Aumann I / Kreis K / Zeidler J / von der Schulenburg JM. Research on the cost of illness for specific occupational diseases caused by isocyanates. Federal Institute for Occupational Safety and Health (Ed.). 2016, ISBN 978-3-88261-032-1
8. Kuhlmann A / Zeidler J / von der Schulenburg JM (Eds.). Socio-economic implications of state intervention in the healthcare sector: National health systems between regulation and liberalisation. Cuvillier Verlag: Göttingen, 2013
9. Zeidler J / Braun S. Secondary data analyses. In: Schöffski O / von der Schulenburg JM (Eds.). Health Economics Evaluations. Springer: Berlin, 4th edition, 2012, 243–274
10. Zeidler J / Kuhlmann A / von der Schulenburg JM (Eds.). Health Systems between Competition and State Intervention: The Influence of the Regulatory Framework on Prices and Structures in Pharmaceutical Markets. Cuvillier Verlag: Göttingen, 2010
11. Prenzler A / von der Schulenburg JM / Zeidler J. Exercises in Public Health and Health Economics. Springer: Berlin, 2010
PhD thesis
1. Zeidler J. Potential and limitations of statutory health insurance (GKV) routine data. Hanover, 2012. Electronic version available at edok01.tib.uni-hannover.de/edoks/e01dh13/734408609.pdf
Discussion Papers
1. Neubauer S / Zeidler J / Lange A / von der Schulenburg JM. Fundamentals and methods of studies using routine data from the statutory health insurance scheme. Hanover, 2014. Electronic version available at diskussionspapiere.wiwi.uni-hannover.de/pdf_bib/dp-534.pdf